Education
About Us
Working with TipRanks
Follow Us
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -5.71M | $ -3.42M | $ -2.84M | $ -2.35M |
| Operating Income | $ 0.00 | $ -76.15M | $ -63.62M | $ -50.50M | $ -15.74M |
| EBITDA | $ 0.00 | $ -74.30M | $ -54.51M | $ -47.47M | $ -13.27M |
| Net Income | $ -70.78M | $ -63.67M | $ -63.74M | $ -50.31M | $ -15.62M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 129.89M | $ 173.42M | $ 184.47M | $ 345.73M | $ 76.74M |
| Total Assets | $ 242.74M | $ 305.56M | $ 350.05M | $ 398.45M | $ 85.01M |
| Total Debt | $ 30.48M | $ 34.63M | $ 30.33M | $ 30.03M | $ 4.78M |
| Net Debt | $ 2.83M | $ 15.23M | $ -84.19M | $ -155.59M | $ -31.83M |
| Total Liabilities | $ 34.01M | $ 40.21M | $ 35.13M | $ 34.87M | $ 114.73M |
| Stockholders' Equity | $ 208.73M | $ 265.35M | $ 314.92M | $ 363.58M | $ -29.72M |
| Cash Flow | |||||
| Free Cash Flow | $ -61.27M | $ -54.15M | $ -48.13M | $ -41.51M | $ -14.92M |
| Operating Cash Flow | $ -59.15M | $ -51.71M | $ -45.81M | $ -39.24M | $ -14.00M |
| Investing Cash Flow | $ 66.25M | $ -43.73M | $ -25.74M | $ -138.96M | $ -25.28M |
| Financing Cash Flow | $ 1.14M | $ 368.00K | $ 562.00K | $ 327.45M | $ 75.90M |